Evidence map›Paper›PMID 32614949›Full record

ArticleBlood2020

VWF maturation and release are controlled by 2 regulators of Weibel-Palade body biogenesis: exocyst and BLOC-2.

Anish V Sharda, Alexandra M Barr, Joshua A Harrison, Adrian R Wilkie, Chao Fang, Lourdes M Mendez, Ionita C Ghiran, Joseph E Italiano, Robert Flaumenhaft

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Case Report: Co-existence of a novelFrontiers in oncology · 2023
    Article
  11. Tip-end fusion of a rod-shaped secretory organelle.Cellular and molecular life sciences : CMLS · 2022
    Article
  12. Circulating Protein Disulfide Isomerase Is Associated with Increased Risk of Thrombosis inClinical cancer research : an official journal of the American Association for Cancer Research · 2021
    Article
  13. Article
  14. Review
  15. Coagulation in Lymphatic System.Frontiers in cardiovascular medicine · 2021
    Review
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Anish V ShardaDivision of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center.
Alexandra M BarrDivision of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center.
Joshua A HarrisonDivision of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center.
Adrian R WilkieDivision of Hematology, Brigham and Women's Hospital.
Chao FangDivision of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center.
Lourdes M MendezDivision of Hematology, Beth Israel Deaconess Medical Center.
Ionita C GhiranDivision of Allergy and Inflammation, Beth Israel Deaconess Medical Center, and.
Joseph E ItalianoDivision of Hematology, Brigham and Women's Hospital.
Robert FlaumenhaftDivision of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center.
Brigham and Women's Hospital · USHadassah Medical Center · IL

Funding

Cytoskeletal Mechanisms of Platelet FormationR01HL068130 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI ITALIANO, JOSEPH E · 2001 to 2021
$8.1M
Thiol Isomerases in Hemostasis and ThrombosisR35HL135775 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI FLAUMENHAFT, ROBERT C · 2017 to 2023
$5.5M
Targeting the Endothelium in SepsisR01HL125275 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI FLAUMENHAFT, ROBERT C, PARIKH, SAMIR M · 2014 to 2018
$4.2M
Vascular Thiol Isomerases in ThrombosisR01HL136394 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI ITALIANO, JOSEPH E, ZWICKER, JEFFREY · 2017 to 2020
$3.3M
NHLBI NIH HHS R01 HL068130NHLBI NIH HHS R01 HL125275NHLBI NIH HHS R01 HL136394NHLBI NIH HHS R35 HL135775
6 · The paper itself

Abstract

von Willebrand factor (VWF) is an essential hemostatic protein that is synthesized in endothelial cells and stored in Weibel-Palade bodies (WPBs). Understanding the mechanisms underlying WPB biogenesis and exocytosis could enable therapeutic modulation of endogenous VWF, yet optimal targets for modulating VWF release have not been established. Because biogenesis of lysosomal related organelle-2 (BLOC-2) functions in the biogenesis of platelet dense granules and melanosomes, which like WPBs are lysosome-related organelles, we hypothesized that BLOC-2-dependent endolysosomal trafficking is essential for WPB biogenesis and sought to identify BLOC-2-interacting proteins. Depletion of BLOC-2 caused misdirection of cargo-carrying transport tubules from endosomes, resulting in immature WPBs that lack endosomal input. Immunoprecipitation of BLOC-2 identified the exocyst complex as a binding partner. Depletion of the exocyst complex phenocopied BLOC-2 depletion, resulting in immature WPBs. Furthermore, releasates of immature WPBs from either BLOC-2 or exocyst-depleted endothelial cells lacked high-molecular weight (HMW) forms of VWF, demonstrating the importance of BLOC-2/exocyst-mediated endosomal input during VWF maturation. However, BLOC-2 and exocyst showed very different effects on VWF release. Although BLOC-2 depletion impaired exocytosis, exocyst depletion augmented WPB exocytosis, indicating that it acts as a clamp. Exposure of endothelial cells to a small molecule inhibitor of exocyst, Endosidin2, reversibly augmented secretion of mature WPBs containing HMW forms of VWF. These studies show that, although BLOC-2 and exocyst cooperate in WPB formation, only exocyst serves to clamp WPB release. Exocyst function in VWF maturation and release are separable, a feature that can be exploited to enhance VWF release.

Indexed as

ExocytosisEndosomesHumansHuman Umbilical Vein Endothelial CellsIntracellular Signaling Peptides and ProteinsLimoninsvon Willebrand FactorWeibel-Palade Bodiesendosidin 2HPS6 protein, humanIntracellular Signaling Peptides and ProteinsLimoninsvon Willebrand Factor

Identifiers

PMID32614949
PMCPMC7731791
OpenAlexW3040582145

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.